Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation

Cancer Research

Volumn 66, Issue 3, 2006, Pages 1751-1757

  Awale, Suresh ^a   Lu, Jie ^b   Kalauni, Surya K ^a   Kurashima, Yukiko ^b   Tezuka, Yasuhiro ^a   Kadota, Shigetoshi ^a   Esumi, Hiroyasu ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARCTIGENIN; GLUCOSE; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENERGY METABOLISM; FEMALE; HERBAL MEDICINE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUTRIENT UPTAKE; OXYGEN SUPPLY; PANCREAS CANCER; PRIORITY JOURNAL; STARVATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ARCTIUM; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FURANS; GLUCOSE; HUMANS; LIGNANS; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 32944457064     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-3143     Document Type: Article

References (31)

1. Tsuzuki Y, Mouta CC, Bockhorn M, et al. Pancreas microenvironment promotes VEGF expression and tumor growth: novel window models for pancreatic tumor angiogenesis and microcirculation. Lab Invest 2001;81:1439-51.
2. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004;363:1049-57.
3. Shore S, Vimalachandran D, Raraty MGT, et al Cancer in the elderly: pancreatic cancer. Surg Oncol 2004;13:201-10.
4. Bardeesy N, Sharpless NE, DePinho RA, et al. The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model. Semin Cancer Biol 2001;11:201-18.
5. Izuishi K, Kato K, Ogura T, et al. Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy. Cancer Res 2000;60:6201-7.
6. Lu J, Kunimoto S, Yamazaki Y, et al. Kigamicin D, a novel anticancer agent based on a new anti-austerity strategy targeting cancer cells' tolerance to nutrient starvation. Cancer Sci 2004;95:547-52.
7. Esumi H, Lu J, Kurashima Y, Hanaoka T. Antitumor activity of pyrvinium pamoate, 6-(dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]- 1-methyl-quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvation. Cancer Sci 2004;95:685-90.
8. Miyamoto T, Min W, Lillehoj HS. Lymphocyte proliferation response during Eimeria tenella infection assessed by a new, reliable, nonradioactive colorimetric assay. Avian Dis 2002;46:10-6.
9. Kuhn DM, Balkis M, Chandra J, et al. Uses and limitations of the XTT assay in studies of Candida growth and metabolism. J Clin Microbiol 2003;41:506-8.
10. Nose M, Fujimoto T, Takeda T, et al. Structural transformation of lignan compounds in rat gastrointestinal tract Planta Med 1992;58:520-3.
11. Nose M, Fujimoto T, Nishibe S, et al. Structural transformation of lignan compounds in rat gastrointestinal tract (II). Planta Med 1993;59:131-4.
12. Dang CV, Semenza GL. Oncogenic alteration of metabolism. Trends Biochem Sci 1999;24:68-71.
13. Southerland RM. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 1988;240:178-84.
14. 2, gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 1997;3:177-82.
15. Hahnfeldt P, Panigrahy D, Folkman J, et al. Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. Cancer Res 1999;59:4770-5.
16. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989;49:6449-65.
17. Dachs GU, Patterson AV, Firth JD, et al. Targeting gene expression of hypoxic cells. Nat Med 1997;3:515-20.
18. Richard DE, Berra E, Pouyssegur J. Angiogenesis. How a tumor adapts to hypoxia. Biochem Biophys Res Commun 1999;266:718-22.
19. Rannibger K, Saldino RM. Arteriographic diagnosis of pancreas lesion. Radiology 1966;86:470-4.
20. Yassa NA, Yang J, Stein S, et al. Gray-scale and color flow sonography of pancreatic ductal adenocarcinoma. J Clin Ultrasound 1997;25:473-80.
21. Megibow AJ. Pancreatic adenocarcinoma: designing the examination to evaluate the clinical questions. Radiology 1992;183:297-303.
22. Hausott B, Greger H, Marian B. Naturally occurring lignans efficiently induce apoptosis in colorectal tumor cells. J Cancer Res Clin Oncol 2003;129:569-76.
23. Hirose M, Yamaguchi T, Lin C, et al. Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MeIQx-induced hepatocarcinogenesis in male F344 rats. Cancer Lett 2000;155:79-88.
24. Takasaki M, Konoshima T, Komatsu K, Tokuda H, Nishino H. Anti-tumor-promoting activity of lignans from the aerial part of Saussurea medusa. Cancer Lett 2000;158:53-9.
25. Cho JY, Kim AR, Yoo ES, Baik KU, Park MH. Immunomodulatory effect of arctigenin, a lignan compound, on tumour necrosis factor-α and nitric oxide production, and lymphocyte proliferation. J Pharm Pharmacol 1999;51:1267-73.
26. Ackler S, Ahmad S, Tobias C, et al. Delayed mammary gland involution in MMTV-AKT1 transgenic mice. Oncogene 2002;21:198-206.
27. Holland EC, Celestino J, Dai C, et al. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 2000;25:55-7.
28. Malstrom S, Tili E, Kappes D, et al. Tumor induction by an Lck-Myr Akt transgene is delayed by mechanisms controlling the size of the thymus. Proc Natl Acad Sci USA 2001;98:14967-72.
29. 31P NMR. Proc Natl Acad Sci U S A 1993;90:2646-50.
30. Gatenby RA. The potential role of transformation-induced metabolic changes in tumor-host interaction. Cancer Res 1995;55:4151-6.
31. Younes M, Lechago LV, Somoano JR, Mosharaf M, Lechago J. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. Cancer Res 1996;56:1164-7.